Prevention of the Pro-Aggressive Effects of Ethanol-Intoxicated Mice by Schisandrin B
暂无分享,去创建一个
[1] Xiankun Tu,et al. Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage , 2022, Chinese Journal of Integrative Medicine.
[2] H. Y. P. Lam,et al. Resolution of systemic complications in Schistosoma mansoni-infected mice by concomitant treatment with praziquantel and Schisandrin B. , 2021, International journal for parasitology.
[3] Tinghong Ye,et al. Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy , 2021, Frontiers in Cell and Developmental Biology.
[4] Hui Wang,et al. Inflammasomes and Fibrosis , 2021, Frontiers in Immunology.
[5] H. Y. P. Lam,et al. Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo , 2021, PLoS neglected tropical diseases.
[6] J. M. Stephen,et al. Effect of alcohol on the central nervous system to develop neurological disorder: pathophysiological and lifestyle modulation can be potential therapeutic options for alcohol-induced neurotoxication , 2021, AIMS neuroscience.
[7] Yuyu Zhang,et al. Schisandrin B Protects against Acute Ethanol-Induced Cardiac Injury by Downregulating Autophagy via the NOX4/ROS Pathway , 2021, Pharmacology.
[8] H. Y. P. Lam,et al. An In-vivo Study into the Effects of Schisandrin B in the Liver, Spleen, Kidney, and Brain of Acute Thioacetamide-intoxicated Mice , 2021, Iranian journal of pharmaceutical research : IJPR.
[9] Jingxiao Gu,et al. Schisandrin B improves cerebral ischemia and reduces reperfusion injury in rats through TLR4/NF-κB signaling pathway inhibition , 2020, Neurological research.
[10] Shinn-Jong Jiang,et al. Albendazole-Schisandrin B Co-Therapy on Angiostrongylus cantonensis-Induced Meningoencephalitis in Mice , 2020, Biomolecules.
[11] Alexandros T. Tzallas,et al. Quantification of Liver Fibrosis—A Comparative Study , 2020 .
[12] Xu Chao,et al. Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway , 2020, Artificial cells, nanomedicine, and biotechnology.
[13] J. McGavock,et al. Improving Knowledge that Alcohol Can Cause Cancer is Associated with Consumer Support for Alcohol Policies: Findings from a Real-World Alcohol Labelling Study , 2020, International journal of environmental research and public health.
[14] J. Ting,et al. The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.
[15] M. Korostyński,et al. Ethanol consumption following mild traumatic brain injury is related to blood‐brain barrier permeability , 2018, Addiction biology.
[16] S. Friedman,et al. Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.
[17] E. Miao,et al. Gasdermins: Effectors of Pyroptosis. , 2017, Trends in cell biology.
[18] Guoqing Zhang,et al. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways , 2017, Drug design, development and therapy.
[19] X. Yang,et al. Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats , 2017, Molecular medicine reports.
[20] P. Ferenci. Hepatic encephalopathy , 2017, Gastroenterology report.
[21] F. Wang,et al. Protective Effects of Lemon Juice on Alcohol-Induced Liver Injury in Mice , 2017, BioMed research international.
[22] Na Liu,et al. Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ , 2017, Inflammation.
[23] J. Connor. Alcohol consumption as a cause of cancer , 2017, Addiction.
[24] K. Kharbanda,et al. Alcoholic Liver Disease: Pathogenesis and Current Management , 2017, Alcohol research : current reviews.
[25] K. Ko,et al. Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver Disease , 2016, Oxidative medicine and cellular longevity.
[26] Fang Wang,et al. The Effects of Syzygium samarangense, Passiflora edulis and Solanum muricatum on Alcohol-Induced Liver Injury , 2016, International journal of molecular sciences.
[27] Xiaohui Yang,et al. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells , 2016, Oncology reports.
[28] Shailender Singh,et al. Alcoholic pancreatitis: New insights into the pathogenesis and treatment. , 2016, World journal of gastrointestinal pathophysiology.
[29] Lei Zhang,et al. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis , 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[30] Chuan-Qi Zhong,et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion , 2015, Cell Research.
[31] J. Hartikainen,et al. Alcohol Abuse Increases Rebleeding Risk and Mortality in Patients with Non-variceal Upper Gastrointestinal Bleeding , 2015, Digestive Diseases and Sciences.
[32] M. Swain,et al. Liver–brain interactions in inflammatory liver diseases: Implications for fatigue and mood disorders , 2014, Brain, Behavior, and Immunity.
[33] B. Gao,et al. Mouse model of chronic and binge ethanol feeding (the NIAAA model) , 2013, Nature Protocols.
[34] D. Lee,et al. Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[35] M. Huang,et al. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo. , 2012, The American journal of Chinese medicine.
[36] D. Kim,et al. Alcoholism and Diabetes Mellitus , 2012, Diabetes & metabolism journal.
[37] E. Negri,et al. Alcohol Consumption and Cancer Risk , 2011, Nutrition and cancer.
[38] Na Chen,et al. Schisandrin B co-treatment ameliorates the impairment on mitochondrial antioxidant status in various tissues of long-term ethanol treated rats. , 2010, Fitoterapia.
[39] D. Mirza,et al. Liver transplantation for alcoholic liver disease. , 2010, World journal of gastroenterology.
[40] S. Zakhari. Overview: How Is Alcohol Metabolized by the Body? , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.
[41] D. Ferriero,et al. Manipulation of Antioxidant Pathways in Neonatal Murine Brain , 2004, Pediatric Research.
[42] C. Lieber,et al. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. , 2004, Alcohol.
[43] K. Weissenborn,et al. Neurology and the liver , 1997, Journal of neurology, neurosurgery, and psychiatry.
[44] T. Macmath. Alcohol and gastrointestinal bleeding. , 1990, Emergency medicine clinics of North America.
[45] S. Ohman,et al. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.
[46] G. Tibbling,et al. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.